US EditionExclusive: Lilly to sell New Jersey facility as it nears picks for new US sites
Summary by endpoints.news
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Exclusive: Lilly to sell New Jersey facility as it nears picks for new US sites
Eli Lilly is selling its Branchburg, NJ manufacturing facility as it shifts capacity away from monoclonal antibodies and toward more complex forms of biologics, the drugmaker told Endpoints News. The Indianapolis-based pharma is entering into ...
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
